We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Andrx Receives Partial Marketing Rights for Generic Lovenox
Andrx Receives Partial Marketing Rights for Generic Lovenox
May 9, 2005
Andrx has signed a deal with Amphastar Pharmaceuticals to purchase partial U.S. marketing rights to a generic version of sanofi-aventis’ blockbuster thrombosis treatment Lovenox.